This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: University Of Louisville Research Foundation, Inc., Other. Active years: 2011-2013.
Company Filing History:
1 out of 398 
1 out of 834,350 Years Active: 2011-2013
Title: Puran S Bora: Innovator in Neovascularization and Age-Related Macular Degeneration
Introduction
Puran S Bora is a notable inventor based in Little Rock, AR (US). He has made significant contributions to the field of medical research, particularly in the areas of neovascularization and age-related macular degeneration (AMD). With a total of 2 patents, his work has the potential to impact therapeutic approaches for various conditions.
Latest Patents
Puran S Bora's latest patents include innovative methods aimed at addressing critical health issues. One patent describes a "Method of inducing neovascularization," which involves injecting a pharmaceutically effective amount of polyethylene glycol (PEG) into tissue to accelerate wound healing and mimic conditions such as age-related macular degeneration, cancer, tumors, and atherosclerosis for further research purposes. Another significant patent focuses on the "Inhibition of wet type age-related macular degeneration (AMD) by adiponectin or acrp 30." This invention provides new methods for treating wet AMD by administering adiponectin or its functional fragments, demonstrating the inhibitory effect of adiponectin on choroidal angiogenesis.
Career Highlights
Throughout his career, Puran S Bora has worked with various organizations, including the University of Louisville Research Foundation, Inc. His research has contributed to a deeper understanding of the mechanisms underlying neovascularization and AMD, paving the way for potential new treatments.
Collaborations
Puran S Bora has collaborated with notable individuals in his field, including Nalini S Bora and Henry J Kaplan. These collaborations have enriched his research and expanded the impact of his inventions.
Conclusion
Puran S Bora's innovative work in the field of neovascularization and age-related macular degeneration highlights his commitment to advancing medical research. His patents reflect a dedication to finding effective treatments for complex health issues.